February 20, 2020
Breakthrough T1D Names New Board Chair, Vice Chair
February 18, 2020
Statement from Aaron J. Kowalski, Ph.D., President and CEO of Breakthrough T1D, on New CDC Diabetes Data
February 14, 2020
Breakthrough T1D Reaches New Milestones in Work to Drive Cures for Type 1 Diabetes and Improve Lives
February 12, 2020
Mount Sinai Discovers New Drug Combo to Induce High Rates of Human Beta Cell Regeneration
February 10, 2020
vTv Therapeutics Announces Positive Results from Part 2 of the Phase 2 Simplici-T1 Study of TTP399, Potential First-in-Class Oral Adjunctive Therapy for Patients with Type 1 Diabetes
February 4, 2020
Breakthrough T1D Calls for Bipartisan Action on Insulin Affordability
February 4, 2020
Breakthrough T1D Honors Type 1 Diabetes Research Leaders
January 28, 2020
General Population Screening Reduces Life Threatening Diabetic Ketoacidosis, New Research Shows
December 20, 2019
A Banner Year for Type 1 Diabetes Breakthroughs
December 19, 2019
Breakthrough T1D Statement on the ACA/Fifth Circuit Decision
